Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Parkinson's Disease

Free Subscription 10.11.2025 2 Brain Res 1 Exp Brain Res 2 J Neural Transm (Vienna) 2 Mov Disord 1 Neurobiol Dis 1 Neurochem Res 1 Neurologia (Engl Ed) 1 PLoS Biol 1 Rev Neurol (Paris)

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Brain Res

1. CHOI H, Hwang SB, Cho HY, Ahn S, et al
   Memantine modulates neuroinflammation and motor coordination in a Parkinson's disease model.
   Brain Res. 2025 Nov 4:150034. doi: 10.1016/j.brainres.2025.150034.
   PubMed         Abstract available
   
   
2. HUANG L, Shu J, Chen Q, Li J, et al
   The underlying mechanism of Erbai decoction on Parkinson's disease rats: a behavioral and pathological study.
   Brain Res. 2025 Oct 31:150008. doi: 10.1016/j.brainres.2025.150008.
   PubMed         Abstract available
   
   

   
   Exp Brain Res

3. DANIELS RJ, Knight CA
   Motor segmentation: a key neuromuscular impairment in people with parkinson's disease.
   Exp Brain Res. 2025;243:241.
   PubMed         Abstract available
   
   

   
   J Neural Transm (Vienna)

4. LEWITT PA, Li J, Auinger P
   Serum L-ornithine-derived polyamines as indicators of Parkinson disease progression.
   J Neural Transm (Vienna). 2025 Nov 3. doi: 10.1007/s00702-025-03007.
   PubMed         Abstract available
   
   
5. PECORARO PM, Carbone SP, Bugamelli F, di Biase L, et al
   Safety of COMT-inhibitors in parkinson's disease: a phase-IV comparative study on adverse events of Tolcapone, Entacapone and Opicapone.
   J Neural Transm (Vienna). 2025 Nov 1. doi: 10.1007/s00702-025-03053.
   PubMed         Abstract available
   
   

   
   Mov Disord

6. PATEL B, Camacho M, Evans JR, Breen DP, et al
   The rs6971 TSPO Polymorphism Does Not Influence Disease Presentation or Progression in Parkinson's Disease rs6971 TSPO Polymorphism in PD.
   Mov Disord. 2025 Nov 3. doi: 10.1002/mds.70105.
   PubMed        
   
   
7. VIRAMETEEKUL S, Shin C, Hirczy SS, Sarva H, et al
   Assessing Digital Health Technologies for Outcome Measurement in Parkinson's Disease Drug Trials: A Systematic Review.
   Mov Disord. 2025 Nov 1. doi: 10.1002/mds.70097.
   PubMed         Abstract available
   
   

   
   Neurobiol Dis

8. NACIRI LC, Melis M, Sollai G, Deligia S, et al
   A multi-dimensional study on taste deficits, alpha-synuclein genetic profiling, and supervised learning for diagnosis and disease severity stratification in Parkinson's disease (PD).
   Neurobiol Dis. 2025 Nov 3:107172. doi: 10.1016/j.nbd.2025.107172.
   PubMed         Abstract available
   
   

   
   Neurochem Res

9. EVINOVA A, Okruhlica I, Racay P, Strnadel J, et al
   Intracellular Calcium Changes Correlate with Mitochondrial Dynamics After Differential Modulation of KATP Channels in a Cellular Model of Parkinson's Disease.
   Neurochem Res. 2025;50:345.
   PubMed         Abstract available
   
   

   
   Neurologia (Engl Ed)

10. BUSTEED L, Horta-Barba A, Reig A, Garcia-Sanchez C, et al
    The discriminative linguistic profiles of progressive supranuclear palsy and Parkinson's disease.
    Neurologia (Engl Ed). 2025;40:830-839.
    PubMed         Abstract available
    
    

    
    PLoS Biol

11. CUI C, Yao Y, Shi Y, Lei J, et al
    Environmental noise-induced changes to the IC-SNc circuit promotes motor deficits and neuronal vulnerability in a mouse model of Parkinson's Disease.
    PLoS Biol. 2025;23:e3003435.
    PubMed         Abstract available
    
    

    
    Rev Neurol (Paris)

12. OPREA E
    Addressing sexual difficulties in Parkinson's disease.
    Rev Neurol (Paris). 2025 Oct 31:S0035-3787(25)00620.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.